Back to Newsroom

Auris Medical Provides Business Update and Reports Second Quarter 2017 Financial Results

Zug, Switzerland, August 10, 2017 – Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today provided a business update and announced financial results for the second quarter ended June 30, 2017.